The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml

Jose R Arribas, Andrzej Horban, Jan Gerstoft, Gerdt Fätkenheuer, Mark Jason Nelson, Nathan Clumeck, Federico Pulido, Andrew Hill, Yvon van Delft, Thomas Stark, Christiane Moecklinghoff

    178 Citationer (Scopus)

    Abstract

    In virologically suppressed patients, darunavir-ritonavir (DRV/r) monotherapy could maintain virological suppression similarly to DRV/r and two nucleosides.
    OriginalsprogEngelsk
    TidsskriftAIDS
    Vol/bind24
    Udgave nummer2
    Sider (fra-til)223-30
    Antal sider8
    DOI
    StatusUdgivet - 16 jan. 2010

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml'. Sammen danner de et unikt fingeraftryk.

    Citationsformater